The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization.

Conclusion. Intravitreal injection of anti-VEGF is effective for idiopathic choroidal neovascularization, and the treatment outcomes are observable after 1 day. OCTA provides a useful approach for monitoring and evaluating the treatment of intravitreal anti-VEGF for CNV. PMID: 27471600 [PubMed]

http://www.ncbi.nlm.nih.gov/pubmed/27471600?dopt=Abstract

Source: Journal of Ophthalmology - July 30, 2016 Category: Opthalmology Tags: J Ophthalmol Source Type: research

More News: Angiography | Eyes | Opthalmology | Study